Pre-analytical requirements for analyzing nucleic acids from blood

Advances in Predictive, Preventive and Personalised Medicine

Volumn 5, Issue , 2015, Pages 45-69

  El Messaoudi, Safia ^a   Thierry, Alain R ^a  

^a INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

Author keywords

Blood sampling; Blood storage; DNA RNA extraction; Plasma; Serum

Indexed keywords

CIRCULATING CELL FREE DNA; DNA; EDETIC ACID; GENOMIC DNA; NUCLEIC ACID; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANALYTICAL PARAMETERS; ARTICLE; BLOOD ANALYSIS; BLOOD COLLECTION TUBE; BLOOD SAMPLING; BLOOD STORAGE; DNA DEGRADATION; DNA EXTRACTION; DNA FRAGMENTATION; DNA ISOLATION; DNA SEQUENCE; FREEZE THAWING; HUMAN; NONHUMAN; NUCLEIC ACID ANALYSIS; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY; STORAGE TEMPERATURE;

EID: 84988667833     PISSN: 22113495     EISSN: 22113509     Source Type: Book Series    
DOI: 10.1007/978-94-017-9168-7_3     Document Type: Article

References (47)

1. Chan KCA, Lo YMD (2007) Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers. Br J Cancer 96:681-685
2. Fleischhacker M, Schmidt B (2007) Circulating nucleic acids (CNAs) and cancer - a survey. Biochim Biophys Acta 1775:181-232
3. Gormally E, Caboux E, Vineis P, Hainaut P (2007) Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 635:105-117
4. Johnson PJ, Lo YM (2002) Plasma nucleic acids in the diagnosis and management of malignant disease. Clin Chem 48:1186-1193
5. Jung K, Fleischhacker M, Rabien A (2010) Cell-free DNA in the blood as a solid tumor biomarker - a critical appraisal of the literature. Clin Chim Acta 411:1611-1624
6. Schwarzenbach H, Hoon DSB, Pantel K (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11:426-447
7. Swarup V, Rajeswari MR (2007) Circulating (cell-free) nucleic acids - a promising, noninvasive tool for early detection of several human diseases. FEBS Lett 581:795-799
8. Tsang JC, Lo YM (2007) Circulating nucleic acids in plasma/serum. Pathology 39:197-207
9. Wagner J (2012) Free DNA - new potential analyte in clinical laboratory diagnostics? Biochem Med (Zagreb) 22:24-38
10. El Messaoudi S, Rolet F, Mouliere F, Thierry AR (2013) Circulating cell-free DNA analysis: preanalytical considerations. Clin Chim Acta 424:222-230
11. Chan KC, Yeung SW, Lui WB, Rainer TH, Lo YM (2005) Effects of preanalytical factors on the molecular size of cell-free DNA in blood. Clin Chem 51:781-784
12. Jen J, Wu L, Sidransky D (2000) An overview on the isolation and analysis of circulating tumor DNA in plasma and serum. Ann N Y Acad Sci 906:8-12
13. Jung M, Klotzek S, Lewandowski M, Fleischhacker M, Jung K (2003) Changes in concentration of DNA in serum and plasma during storage of blood samples. Clin Chem 49:1028-1029
14. Lee TH, Montalvo L, Chrebtow V, Busch MP (2001) Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. Transfusion 41:276-282
15. Lui YY, Chik KW, Chiu RW, Ho CY, Lam CW, Lo YM (2002) Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 48:421-427
16. Steinman CR (1975) Free DNA in serum and plasma from normal adults. J Clin Invest 56:512- 515
17. Thijssen MA, Swinkels DW, Ruers TJ, de Kok JB (2002) Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases. Anticancer Res 22:421-425
18. Umetani N, Hiramatsu S, Hoon DS (2006) Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminating extraneous DNA during separation. Ann N Y Acad Sci 1075:299-307
19. Lam NY, Rainer TH, Chiu RW, Lo YM (2004) EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis. Clin Chem 50:256-257
20. Thierry AR, Mouliere F, Gongora C, Ollier J, Robert B, Ychou M, Del Rio M, Molina F (2010) Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res 38:6159-6175
21. Beutler E, Gelbart T, Kuhl W (1990) Interference of heparin with the polymerase chain reaction. Biotechniques 9:166
22. Streck: A standardized method for sample collection, stabilization and transport of cell-free plasma DNA. http://www.streck.com/product.aspx?p=Cell-Free%20DNA%20BCT
23. Holdenrieder S, Stieber P, Bodenmüller H, Fertig G, Fürst H, Schmeller N, Untch M, Seidel D (2001) Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med 39:596-605
24. Norton SE, Luna KK, Lechner JM, Qin J, Fernando MR (2013) A new blood collection device minimizes cellular DNA release during sample storage and shipping when compared to a standard device. J Clin Lab Anal 27(4):305-311
25. Tatsumi N, Miwa S, Lewis SM (2002) Specimen collection, storage, and transmission to the laboratory for hematological tests. Int J Hematol 75:261-268
26. Laktionov PP, Tamkovich SN, Rykova EY, Bryzgunova OE, Starikov AV, Kuznetsova NP, Vlassov VV (2004) Cell-surface-bound nucleic acids: free and cell-surface-bound nucleic acids in blood of healthy donors and breast cancer patients. Ann N Y Acad Sci 1022:221-227
27. Angert RM, LeShane ES, Lo YM, Chan LY, Delli-Bovi LC, BianchiDW(2003) Fetal cell-free plasma DNA concentrations in maternal blood are stable 24 hours after collection: analysis of first- and third-trimester samples. Clin Chem 49:195-198
28. Barrett AN, Zimmermann BG, Wang D, Holloway A, Chitty LS (2011) Implementing prenatal diagnosis based on cell-free fetal DNA: accurate identification of factors affecting fetal DNA yield. PLos One 6(10):e25202
29. Board RE, Williams VS, Knight L, Shaw J, Greystoke A, Ranson M, Dive C, Blackhall FH, Hughes A (2008) Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer. Ann N Y Acad Sci 1137:98-107
30. Lui YY, Chik KW, Lo YM (2002) Does centrifugation cause the ex vivo release of DNA from blood cells? Clin Chem 48:2074-2076
31. Xue X, Teare MD, Holen I, Zhu YM, Woll PJ (2009) Optimizing the yield and utility of circulating cell-free DNA from plasma and serum. Clin Chim Acta 404:100-104
32. Wong D, Moturi S, Angkachatchai V, Mueller R, DeSantis G, van den Boom D, Ehrich M (2013) Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing. Clin Biochem 46(12):1099-1104
33. Das K, Fernando MR, Basiaga S, Wigginton SM, Williams T (2014) Effects of a novel cell stabilizing reagent on DNA amplification by PCR as compared to traditional stabilizing reagents. Acta Histochem 116:55-60. doi:10.1016/j.acthis.2013.05.002
34. Fernando MR, Chen K, Norton S, Krzyzanowski G, Bourne D, Hunsley B, Ryan WL, Bassett C (2010) A new methodology to preserve the original proportion and integrity of cell-free fetal DNA in maternal plasma during sample processing and storage. Prenat Diagn 30(5):418-424
35. Hidestrand M, Stokowski R, Song K, Oliphant A, Deavers J, Goetsch M, Simpson P, Kuhlman R, Ames M, Mitchell M, Tomita-Mitchell A (2012) Influence of temperature during transportation on cell-free DNA analysis. Fetal Diagn Ther 31:122-128
36. van Wijk IJ, de Hoon AC, Jurhawan R, Tjoa ML, Griffioen S, Mulders MA, van Vugt JM, Oudejans CB (2000) Detection of apoptotic fetal cells in plasma of pregnant women. Clin Chem 46:729-731
37. Poon LL, Leung TN, Lau TK, Lo YM (2000) Prenatal detection of fetal Down's syndrome from maternal plasma. Lancet 356:1819-1820
38. Chiu RW, Poon LL, Lau TK, Leung TN, Wong EM, Lo YM (2001) Effects of bloodprocessing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 47:1607-1613
39. Swinkels DW, Wiegerinck E, Steegers EA, de Kok JB (2003) Effects of blood-processing protocols on cell-free DNA quantification in plasma. Clin Chem 49:525-526
40. Gahan PB, Stroun M (2010) The virtosome-a novel cytosolic informative entity and intercellular messenger. Cell Biochem Funct 28:529-538
41. Holdenrieder S, Mueller S, Stieber P (2005) Stability of nucleosomal DNA fragments in serum. Clin Chem 51:1026-1029
42. Frattini M, Balestra D, Verderio P, Gallino G, Leo E, Sozzi G, Pierotti MA, Daidone MG (2005) Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients. J Clin Oncol 23:3163-3164
43. Holdenrieder S, Von Pawel J, Nagel D, Stieber P (2010) Long-term stability of circulating nucleosomes in serum. Anticancer Res 30:1613-1615
44. Lee T, LeShane ES, Messerlian GM, Canick JA, Farina A, Heber WW, Bianchi DW (2002) Down syndrome and cell-free fetal DNA in archived maternal serum. Am J Obstet Gynecol 187:1217-1221
45. Sozzi G, Roz L, Conte D, Mariani L, Andriani F, Verderio P, Pastorino U (2005) Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays. J Natl Cancer Inst 97:1848-1850
46. Thierry AR, Mouliere F, El Messaoudi S, Mollevi C, Lopez-Crapez E, Rolet F, Gillet B, Gongora C, Dechelotte P, Robert B, Del Rio M, Lamy PJ, Bibeau F, Nouaille M, Loriot V, Jarrousse AS, Molina F, Mathonnet M, Pezet D, Ychou M (2014) Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat Med 20(4):430- 435
47. Kopreski MS, Benko FA, Kwee C, Leitzel KE, Eskander E, Lipton A, Gocke CD (1997) Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. Br J Cancer 76:1293-1299